Riskpilot← Back to searchSign inGet full accessSKINMED.NO AS
ASActiveOrg 924359013Storgata 2, 2815 GjøvikOther human health activities n.e.c. · NACE 8699Est. 20202 employees
Revenue 2024
NOK 880K
+65% vs 2023
EBITDA margin
3.5%
+105% vs 2023
Equity ratio
-222.7%
Financial strength
Net profit 2024
NOK -10K
+98% vs 2023
| Revenue | NOK 880K | +65% |
| EBITDA | NOK 31K | +105% |
| Net profit | NOK -10K | +98% |
| Total assets | NOK 537K | +4% |
| Equity | NOK -1,2M | -1% |
| Employees | 2 | — |
Legal name
SKINMED.NO AS
Org number
924359013
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
7. januar 2020
Share capital
NOK 70 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Gjennom hel- eller deleide selskaper eller ved samarbeid med andre virksomheter, å drive forretning innen hudterapi og beslektet virksomhet, samt drive detaljsalg innen varehandel, annet beslektet med dette som kurs- og konsulentvirksomhet, finansiering og anbringelse av selskapets midler i aksjer og andre verdipapirer i andre selskaper eller ved investering i eiendom eller på annen måte.
Address
Storgata 2, 2815 Gjøvik
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 472 | 643 | 737 | 534 | 880 |
| Staff expenses | −1 | −130 | −482 | −341 | −130 |
| EBITDA | −26 | −268 | −547 | −593 | 31 |
| Depreciation & amort. | −7 | −6 | −14 | −27 | −17 |
| EBIT | −33 | −274 | −562 | −620 | 13 |
| Net financials | −10 | −13 | −34 | −51 | −27 |
| Profit before tax | −43 | −287 | −596 | −671 | −13 |
| Tax | −10 | −63 | −123 | −147 | −3 |
| Net profit | −34 | −224 | −473 | −524 | −10 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 207 | 236 | 415 | 517 | 537 |
| Equity | 36 | −188 | −661 | −1 185 | −1 195 |
| Long-term debt | 169 | 275 | 215 | 155 | 91 |
| Short-term debt | 1 | 149 | 861 | 1 547 | 1 641 |
| Total debt | 171 | 424 | 1 076 | 1 702 | 1 732 |
EBITDA margin
3.5%
This company
15.8%
Market median
-78% vs market
20202024
Equity ratio
-222.7%
This company
38.2%
Market median
-683% vs market
20202024
Return on equity
-1045200.0%
This company
18.4%
Market median
-5680535% vs market
20202024
Net profit margin
-1.2%
This company
8.1%
Market median
-115% vs market
20202024
Asset turnover
1.64×
This company
1.12×
Market median
+46% vs market
20202024
Debt / equity
1.45×
This company
0.62×
Market median
-134% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
GK Chief Executive Officer | Chief Executive Officer | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Chairman | 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SKINMED.NO AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Guro Karina Bakke | Chief Executive Officer | 0 companies |
| Cecilie Skinnerud Engen | Chairman | 0 companies |
| Einar Sagstuen | Board of Directors | 0 companies |
| Sondre Sagstuen | Chairman | 0 companies |